Task: Answer the multiple choice question.
Query: Which drug exhibits a 3.073% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CC(NC(=O)c1ccc(NC2=NC3CS(=O)(=O)CC3S2)cc1)c1ccccc1
b FC(F)(F)c1cc(-c2ccc(Cl)cc2)nc(NCc2cccnc2)n1
Answer: b. FC(F)(F)c1cc(-c2ccc(Cl)cc2)nc(NCc2cccnc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
FC(F)(F)c1cc(-c2ccc(Cl)cc2)nc(NCc2cccnc2)n1
FC(F)(F)c1cc(-c2ccc(Cl)cc2)nc(NCc2cccnc2)n1
4-(4-chlorophenyl)-N-(pyridin-3-ylmethyl)-6-(trifluoromethyl)pyrimidin-2-amine